Skip to main content
Diabetes Type 1 Diabetes

Type 1 Diabetes

Open Access Diabetic Nephropathy Review

Managing lipids in diabetic kidney disease

People with diabetic kidney disease have an increased risk of cardiovascular disease but good lipid management can improve outcomes. Find out more with these practical recommendations.

Editor's Choice

Immune checkpoint inhibitor-induced diabetes

Free for a limited time Other Specific Types of Diabetes Review

ICIs have advanced cancer treatment but can trigger immune-related adverse events. Explore the pathogenesis, progression, and treatment strategies for ICI-induced diabetes.

Hyperglycemic crises in adults with diabetes: a consensus report

Open Access Hyperglycemia Review

Update on the epidemiology, pathophysiology, and clinical presentation of DKA and HHS in adults with diabetes, with recommendations for diagnosis, treatment, and prevention.

Understanding bone metabolism in diabetes

Open Access Diabetes Review

Skeletal fragility in diabetes is associated with a significant clinical burden. Using diabetes-specific parameters may help address gaps in the assessment and management of diabetic bone disease.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Episode 10: Disease-modifying therapy for type 1 diabetes

Reducing the burden of type 1 diabetes

Despite many recent advances in its management, type 1 diabetes remains a burden for those living with the condition.

Prof. Chantal Mathieu explains the progress being made with disease-modifying therapy for type 1 diabetes and how it has the potential to transform the current treatment landscape.

Prof. Chantal Mathieu

Using CGM to optimize type 2 diabetes management with non-intensive insulin treatment in primary care

With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report. 

Supported by: Abbott Diabetes Care

Prof. Samuel Seidu
Developed by: Adis

Case Studies

Managing exogenous insulin antibody syndrome

Open Access Type 1 Diabetes Case Study

EIAS can cause hyperglycemia, hypoglycemia, and ketoacidosis in people with diabetes. This case in an older adult with type 1 diabetes shows how EIAS can be managed in an outpatient setting.

ICI-induced insulin-dependent diabetes without islet autoantibodies

Diabetes Case Study

Rapidly progressive insulin-dependent diabetes in the absence of islet autoantibodies developed 2 years after starting treatment with the immune checkpoint inhibitor nivolumab.

Type 1 diabetes after COVID-19 vaccination

This case report considers two cases of type 1 diabetes diagnosed after multiple COVID-19 vaccinations. HLA haplotypes associated with susceptibility to type 1 diabetes were present in both cases.

Insulins Clinical Trial Summary

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.

Developed by: Springer Medicine

Current Reviews

Safety and Psychological Outcomes of Tandem t:Slim X2 Insulin Pump with Control-IQ Technology in Children, Adolescents, and Young Adults with Type 1 Diabetes: A Systematic Review

Open Access Type 1 Diabetes Review

The Tandem t:slim X2 insulin pump is a second-generation automated insulin delivery system with Control-IQ technology. It consists of an X2 insulin pump, an integrated Dexcom sensor, and an embedded ‘Control-IQ’ algorithm, which predicts glucose …

Use of diabetes technology in children

Open Access Type 1 Diabetes Review

Children with type 1 diabetes and their caregivers face numerous challenges navigating the unpredictability of this complex disease. Although the burden of managing diabetes remains significant, new technology has eased some of the load and …

Technology advances in diabetes pregnancy: right technology, right person, right time

Open Access Type 1 Diabetes Review

This review outlines some of the extraordinary recent advances in diabetes technology, which are transforming the management of type 1 diabetes before, during and after pregnancy. It highlights recent improvements associated with use of continuous …

Down Syndrome and Autoimmune Disease

Open Access Trisomy 21 Review

Down syndrome is the most common genetic cause of intellectual disability and has previously been associated with a variety of autoimmune disorders affecting multiple organ systems. The high prevalence of autoimmune disease, in conjunction with …

Webinar | 08-11-2023 | 18:00 (CET)

Keynote webinar | Spotlight on diet and diabetes

An expert-led symposium exploring the prevention and management of type 2 diabetes through dietary interventions. Highlights include discussion of the recent EASD guidelines, therapeutic diets, food types and processing, plus psychological factors that influence patient success, and the drivers of healthy eating and diabetes control.

Prof. Mike Lean
Prof. Falko Sniehotta
Developed by: Springer Medicine

CME & eLearning

Tweetorials | Vodcasts | Infographics (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)

Stay up to date with the rapidly changing CGM landscape. Learn how to implement and integrate CGM into diabetes management to improve patient care and outcomes.

Supported by:
  • Abbott
Developed by: Springer Healthcare IME

Further Reading

Healthcare costs and medical utilization patterns associated with painful and severe painful diabetic peripheral neuropathy

Open Access Diabetic Foot Original Article

Diabetes prevalence rates have been increasing in recent years, making it one of the most common diseases in the world. In 2019 in the United States, it was estimated that ~37.3 million people had some form of diabetes (diabetes type 1, 2, or …

Evaluation of Cardiovascular Risk in People with Type 1 Diabetes: A Comprehensive and Specific Proposed Practical Approach

Open Access Type 1 Diabetes Practical Approach

People living with type 1 diabetes (T1D) have an increased risk of cardiovascular disease (CVD), and it is the leading cause of morbidity and mortality in this population. CVD risk increases with each uncontrolled risk factor, even in individuals …

tRNA-derived fragments in T lymphocyte–beta cell crosstalk and in type 1 diabetes pathogenesis in NOD mice

Open Access Type 1 Diabetes Original Research

Type 1 diabetes is characterised by the invasion of the islets of Langerhans by immune cells and by an autoimmune attack against insulin-secreting beta cells. The autoimmune reaction culminates in a near-complete elimination of beta cells …

Higher fibre and lower carbohydrate intake are associated with favourable CGM metrics in a cross-sectional cohort of 470 individuals with type 1 diabetes

Open Access Type 1 Diabetes Original Research

In individuals with type 1 diabetes, continuous glucose monitoring (CGM) has shown consistent benefit as compared with self-monitoring of blood glucose in reducing HbA 1c and episodes of hypoglycaemia [ 1 ], and has therefore become the standard of …